Clinical Trial Update: Efficacy and Safety of AD-35 in Treatment of Subjects With Mild to Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update reporting on efficacy and safety of AD-35 in adults with mild to moderate Alzheimer's Disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Alzheimer Disease Early Onset

Drugs mentioned

• AD-35

Snippet

Sponsor: Zhejiang Hisun Pharmaceutical Co. Ltd. | Conditions: Alzheimer Disease, Early Onset | Phase 2 | Status: UNKNOWN